Source:http://linkedlifedata.com/resource/pubmed/id/18083911
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2008-2-25
|
pubmed:abstractText |
The recent identification of the trace amine-associated receptor (TAAR)1 provides an opportunity to dissociate the effects of trace amines on the dopamine transporter from receptor-mediated effects. To separate both effects on a physiological level, a Taar1 knockout mouse line was generated. Taar1 knockout mice display increased sensitivity to amphetamine as revealed by enhanced amphetamine-triggered increases in locomotor activity and augmented striatal release of dopamine compared with wild-type animals. Under baseline conditions, locomotion and extracellular striatal dopamine levels were similar between Taar1 knockout and wild-type mice. Electrophysiological recordings revealed an elevated spontaneous firing rate of dopaminergic neurons in the ventral tegmental area of Taar1 knock-out mice. The endogenous TAAR1 agonist p-tyramine specifically decreased the spike frequency of these neurons in wild-type but not in Taar1 knockout mice, consistent with the prominent expression of Taar1 in the ventral tegmental area. Taken together, the data reveal TAAR1 as regulator of dopaminergic neurotransmission.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Amphetamine,
http://linkedlifedata.com/resource/pubmed/chemical/Dopamine Antagonists,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, G-Protein-Coupled,
http://linkedlifedata.com/resource/pubmed/chemical/Trace amine-associated receptor 1
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1521-0103
|
pubmed:author |
pubmed-author:BettlerBernhardB,
pubmed-author:BluethmannHorstH,
pubmed-author:BorroniEdilioE,
pubmed-author:BradaiaAmyaouchA,
pubmed-author:HoenerMarius CMC,
pubmed-author:JeanneauKarineK,
pubmed-author:LindemannLotharL,
pubmed-author:MeyerClaas AikoCA,
pubmed-author:MoreauJean-LucJL,
pubmed-author:OzmenLaurenceL,
pubmed-author:WettsteinJoseph GJG
|
pubmed:issnType |
Electronic
|
pubmed:volume |
324
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
948-56
|
pubmed:dateRevised |
2008-5-13
|
pubmed:meshHeading |
pubmed-meshheading:18083911-Amphetamine,
pubmed-meshheading:18083911-Animals,
pubmed-meshheading:18083911-Dopamine,
pubmed-meshheading:18083911-Dopamine Antagonists,
pubmed-meshheading:18083911-Male,
pubmed-meshheading:18083911-Mice,
pubmed-meshheading:18083911-Mice, Inbred C57BL,
pubmed-meshheading:18083911-Mice, Knockout,
pubmed-meshheading:18083911-Motor Activity,
pubmed-meshheading:18083911-Neurons,
pubmed-meshheading:18083911-Receptors, G-Protein-Coupled,
pubmed-meshheading:18083911-Ventral Tegmental Area
|
pubmed:year |
2008
|
pubmed:articleTitle |
Trace amine-associated receptor 1 modulates dopaminergic activity.
|
pubmed:affiliation |
Pharmaceuticals Division, Central Nervous System Research, Department PRDNP5 CH, Bldg. 70/331, F. Hoffmann-La Roche Ltd., CH-4070 Basel, Switzerland.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|